Sie sind hier
Inhalt - 2012
2012
 No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial | 07.05.2012 (Marcel Stöckle) Grijsen M. Et al.: No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial PLoS Medicine 9 Issue 3 2012 |
| Cefpodoxime vs Ciprofloxacin for Shourt-Course Treatment of Acute Uncomplicated Cystitis | 30.04.12 (Dominique Fasel) Thomas M. Hootom et al.: Cefpodoxime vs Ciprofloxacin for Shourt-Course Treatment of Acute Uncomplicated Cystitis JAMA February 8, 2012-Vol 307, No 6. 583-589 2012 |
| Screening for tuberculosis in asylum seekers: comparison of chest radiography with an interview-based system | 23.04.2012 (Evelin Bucheli) S. Schneeberger Geisler: Screening for tuberculosis in asylum seekers: comparison of chest radiography with an interview-based system Int J Tuberc Lung Dis 14 1388-1394 2010 |
| Administration of Voriconazole in patients with renal dysfunction | 26.03.12 (Elisabeth Wehrle) Neofytos et al. Administration of Voriconazole in patients with renal dysfunction CID 54 913-921 2012 |
| Long-Term Outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients | 12.3.2012 (Nina Khanna) Heslop H. et al. Long-Term Outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients Blood 115 925-35 2010 |
| Household Versus Individual Approaches to Eradication of Communitiy-Associated Staphylococcus aureus in Children: A Randomized Trial | 05.03.2012 (Veronika Bättig) Fritz et al. Household Versus Individual Approaches to Eradication of Communitiy-Associated Staphylococcus aureus in Children: A Randomized Trial CID 54 743-51 2012 |
| Host and Pathogen Factors for Clostridium difficile Infection and Colonisation | 20.02.2012 (Esther Künzli) Loo et al. Host and Pathogen Factors for Clostridium difficile Infection and Colonisation NEJM 365 1693-703 2011 |
| Schweizerischer Impfplan 2012 | 13.02.2012 (Marcel Stöckle) Bundesamt für Gesundheit: Schweizerischer Impfplan 2012 BAG Bulletin 6 105-15 2012 |
| Laminar Airflow Ceiling Size: No Impact on Infection Rates Following Hip and Knee Prosthesis | 06.02.2012 (Evelin Bucheli) Breier A. et al.:Laminar Airflow Ceiling Size: No Impact on Infection Rates Following Hip and Knee Prosthesis Infect Conrtol Hosp Epidemiol 32 1097-1102 |
| ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum ß-Lactamase–producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts | 30.01.2012 (Danielle Vuichard) Jesús Rodríguez-Baño: ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum ß-Lactamase–producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts Clinical Infectious Diseases 54(2) 167–74 2012 |
| Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials | 23.01.2012 (D.Fasel) Hester L van den Hoek: Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials BMJ November 2011, 7830 1-10 2011 |
| Outcomes of moderate to severe pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients | 16.1.12 (Baharak Babouee) Mi Moon et al.: Outcomes of moderate to severe pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients Antimicrob Agents Chemother 55 1413-18 2011 |
| Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection | 9.1.2012 (Stefan Erb) Sterling et al.: Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection NEJM 23 2155-66 2011 |
